Position in HLN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$115,813
-$8,421 QoQ
Shares Held
12,413
+0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#363
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ballew Advisors, Inc holds $115,813 across 1 Drug Manufacturers - Specialty & Generic name. HLN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
This page
|
12,413 | $115,813 |
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,813 | 12,413 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $124,234 | 12,411 | Shares | Sole | 2026-04-10 | |
| 2025-12-31 | $125,475 | 12,411 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $111,326 | 12,411 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $133,420 | 12,866 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $132,319 | 12,859 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $122,674 | 12,859 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $136,048 | 12,859 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $106,190 | 12,856 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $106,948 | 12,597 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $103,673 | 12,597 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $104,908 | 12,594 | Shares | Sole | 2023-10-06 | |
| 2023-06-30 | $105,537 | 12,594 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $102,515 | 12,594 | Shares | Sole | 2023-07-06 | |
| 2022-12-31 | $100,720 | 12,590 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $76,673 | 12,590 | Shares | Sole | 2022-10-11 | |
| No filing history on record for this holder in this stock. | ||||||